SCHEMBL309068

SCHEMBL309068

CCCNCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24636779 0.94 CA12 (0.42)
SCHEMBL23316152 0.84
Ethylamine SCHEMBL2885890 0.81 TSHR (0.44)
SCHEMBL308713 0.80
SCHEMBL28944885 0.80
Propylamine SCHEMBL258912 0.79 CA12 (0.50)
SCHEMBL7151277 0.78
Methylamine SCHEMBL352966 0.77
SCHEMBL15445 0.76
SCHEMBL17626634 0.76 TSHR (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3844159-B1 NOVEL PYRROLIDINYL AMIDE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE HOFFMANN LA ROCHE (CH) 2023-05-03 EP claimed
EP-1109449-B1 MICROCAPSULE FORMULATIONS BAYER AG (DE) 2002-11-06 EP claimed
EP-0317876-B1 Process for making a phthalocyanine pigment dispersion BASF CORP (US) 1994-07-27 EP claimed
US-4859770-A Process for making alpha-phase phthalocyanine blue pigment comprising substantially 100 percent isometric crystals BASF CORPORATION (US) 1989-08-22 US claimed
US-4853039-A Process for making a phthalocyanine pigment dispersion BASF CORPORATION (US) 1989-08-01 US claimed
US-20230355705-A1 DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS THE UNIVERSITY OF HONG KONG (CN) 2023-11-09 US disclosed
WO-2023141350-A1 SYSTEMS AND METHODS FOR NUCLEAR MAGNETIC RESONANCE (NMR) WELL LOGGING CONOCOPHILLIPS COMPANY (US) 2023-07-27 WO disclosed
CN-115089547-A Artificial tears, contact lenses, and drug carrier compositions and methods of use thereof PS治疗有限公司 2022-09-23 CN disclosed
US-11357767-B2 Compounds for use in treating depression and migraine KHONDRION IP B.V. (NL) 2022-06-14 US disclosed
US-20220092500-A1 CONTROL SYSTEM WITH INCENTIVE-BASED CONTROL OF BUILDING EQUIPMENT JOHNSON CONTROLS TECHNOLOGY COMPANY (US) 2022-03-24 US disclosed
EP-2596805-B1 Prodrug comprising a drug-linker conjugate ASCENDIS PHARMA AS (DK) 2021-10-27 EP disclosed
US-20200289491-A1 Novel compounds for use in treating depression and migraine KHONDRION IP B.V. (NL) 2020-09-17 US disclosed
US-4859770-A Process for making alpha-phase phthalocyanine blue pigment comprising substantially 100 percent isometric crystals BASF CORPORATION (US) 1989-08-22 US disclosed
US-4853039-A Process for making a phthalocyanine pigment dispersion BASF CORPORATION (US) 1989-08-01 US disclosed
EP-0317876-A2 Process for making a phthalocyanine pigment dispersion BASF Corporation (US) 1989-05-31 EP disclosed
US-4066644-A CNS DEPRESSANTS, ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1978-01-03 US disclosed
US-4066643-A CNS DEPRESSANTS, ANTIINFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1978-01-03 US disclosed
US-4033958-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1977-07-05 US disclosed
US-4022782-A ANTI-INFLAMMATORY AGENTS E. R. SQUIBB & SONS, INC. (US) 1977-05-10 US disclosed
US-3994893-A ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-11-30 US disclosed